EF Johnson Technologies, Inc. Announces First Quarter 2009 Financi...(March 31 2008 (Unaudited and in th...),Health

Date:5/6/2009

March 31, 2008 (Unaudited and in thousands, except share and per share data) 2009 2008 (as restated) Revenues $22,429 $33,899 Cost of sales 14,731 22,505 Gross profit 7,698 11,394 Operating expenses: Research and development 3,331 3,255 Sales and marketing 2,476 3,166 General and administrative 5,423 6,401 Amortization of intangibles 246 407 Escrow fund settlement (2,804) - Total operating expenses 8,672 13,229 Loss from operations (974) (1,835) Interest expense, net (284) (181) Loss before income taxes (1,258) (2,016) Income tax benefit (expense) - - Net loss $(1,258) $(2,016) Net loss per share-Basic and dilutive $(0.05) $(0.08) Weighted average common shares-Basic and dilutive 26,383,931 26,062,748

'/>"/>

SOURCE EF Johnson Technologies, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
2. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Trust for Americas Health Receives $7.6 Million Grant from the Robert Wood Johnson Foundation to Advance the Quality and Impact of the Public Health System
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Johnson & Johnson Tops Annual Pharmaceutical Company Rankings in a New Report From Industry-Leading Publication Scrip
7. Independence Technology, A Johnson & Johnson Company, Renews Its Contract With Creative Technology Services
8. Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals
9. Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions
10. UAN Mourns Passing of President Cheryl L. Johnson, RN
11. Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate